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ORIGINAL ARTICLE
Vascular change and opposing effects of the angiotensin type 2
receptor in a mouse model of vascular cognitive impairment
Martina Füchtemeier1,2, Marie P Brinckmann1, Marco Foddis1, Alexander Kunz1, Chrystelle Po3, Caterina Curato4,5,
Ulrich Dirnagl1,2,5,6 and Tracy D Farr1
Our aims were to assess the spatiotemporal development of brain pathology in a mouse model of chronic hypoperfusion using
magnetic resonance imaging (MRI), and to test whether the renin-angiotensin system (RAS) can offer therapeutic beneﬁt. For the
ﬁrst time, different patterns of cerebral blood ﬂow alterations were observed in hypoperfused mice that ranged from an immediate
and dramatic to a delayed decrease in cerebral perfusion. Diffusion tensor imaging revealed increases in several quantitative
parameters in different brain regions that are indicative of white-matter degeneration; this began around 3 weeks after induction of
hypoperfusion. While this model may be more variable than previously reported, neuroimaging tools represent a promising way to
identify surrogate markers of pathology. Vascular remodelling was observed in hypoperfused mice, particularly in the anterior part
of the Circle of Willis. While the angiotensin II receptor type 2 agonist, Compound 21 (C21), did not inﬂuence this response, it did
promote expansion of the basilar artery in microcoil animals. Furthermore, C21-treated animals exhibited increased brain
lymphocyte inﬁltration, and importantly, C21 had opposing effects on spatial reference memory in hypoperfused and sham mice.
These results suggest that the RAS may have a role in vascular cognitive impairment.
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INTRODUCTION
Vascular cognitive impairment (VCI) refers to a group of cognitive
disorders that are presumed to share a vascular origin; together
they represent the second leading cause of dementia after
Alzheimer’s disease. The exact pathophysiology of VCI is not
understood, but the incidence and known risk factors (hyperten-
sion, atherosclerosis, advanced age, and obesity) are on the rise.
Despite identiﬁcation of VCI as a top research priority for the next
10 years by the Stroke Progress Review Group at the National
Institute of Neurological Disorders and Stroke, the development of
appropriate preclinical animal models is lagging.1 It is generally
accepted that there is a causal link between chronic brain hypo-
perfusion and cognitive impairment in a rat model of bilateral
common carotid artery occlusion,2 and a comparable mouse
model was developed in which both carotid arteries were made
stenotic using small microcoils.3 The authors reported white-
matter lesions in the corpus callosum at 14 days after microcoil
implantation, which is a useful hallmark of certain subtypes of VCI.
Since then, a few reports have described similar ﬁndings, as well
as spatial working memory impairments after 1 to 2 months of
hypoperfusion.4,5 Another group reported hippocampal degen-
eration when survival times were extended to 8 months,6 and, by
bilaterally varying the degree of stenosis, one group observed
microinfarcts within the most severely deprived cortex.7
Nevertheless, a great deal of work is still required to charac-
terize this model, identify pathophysiologic mechanisms that are
relevant to certain aspects of the human condition, and to ﬁnd
therapeutic strategies. Therefore, the purpose of the present study
was twofold. First, we aimed to establish a timeline of neuro-
degeneration using noninvasive, longitudinal neuroimaging, thus
providing surrogate measures of neuropathology that would be
equally applicable to humans. Second, we aimed to counteract the
deleterious effects of brain hypoperfusion by pharmacologically
modulating the renin-angiotensin system (RAS). Angiotensin II is
a hormone that induces vasoconstriction and increases blood
pressure via stimulation of the angiotensin II type 1 receptor.
Angiotensin II type 1 receptors are widely expressed and have a
detrimental role in cardiovascular and neurologic disease. Angio-
tensin II type 2 receptors (AT2Rs) are expressed in lower levels in
regions of the brain that are involved in cognition, where they
oppose the actions of angiotensin II type 1 receptors and are
generally thought to provide the protective arm of the RAS.8 The
speciﬁc nonpeptide, orally active AT2R agonist Compound 21
(C21) has already been shown to reduce cognitive decline in a
mouse model of Alzheimer’s disease9 and has been suggested to
promote regeneration and reduce inﬂammation,10 thus, it
represents an excellent candidate for use in VCI.
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MATERIALS AND METHODS
Animals and Experimental Design
All experiments were performed in accordance with the German Animal
Welfare Act and approved by the Landesamt für Gesundtheit und Soziales.
Male C57/BL6 mice (10 weeks of age) were housed in a temperature
(22 ± 2°C), humidity (55 ± 10%), and light (12/12 hours light/dark cycle)
controlled environment. Animals were given ad libitum access to food and
water throughout the duration of the experiments and monitored daily. No
differences were observed in terms of the general condition, appearance,
and behavior of the mice after surgery. All mice were active, grooming,
feeding, and drinking post operatively and virtually no weight loss was
exhibited.
During the ﬁrst experiment (Figure 1A) eight mice that underwent
microcoil implantation were imaged repetitively (before and at 4 and
24 hours, and 11, 17, and 25 days after microcoil implantation) for
quantitative estimation of cerebral blood ﬂow (CBF). Diffusion tensor
imaging (DTI) was also acquired at the ﬁnal three timepoints. Exclusion
criteria stipulated that any animal with an adverse outcome that met local
criteria for euthanasia would be excluded as well as any magnetic
resonance imaging (MRI) measurement in which severe motion artefact
was present. No measurements or animals were excluded from the
analysis.
During the second experiment (Figure 1B), which was performed in two
separate rounds, mice were divided into four different groups based on
housing arrangements: (1) Sham, Vehicle (n=22), (2) Sham, C21 (n= 11), (3)
Microcoil, Vehicle (n= 26), and (4) Microcoil, C21 (n= 13). The experi-
menters were blinded to the condition of the animals. Mice were trained
in the pole test and tested 1 week before, and at 7 and 14 days after
microcoil implantation, or the corresponding sham procedure. Also
starting at the time of surgery, mice began receiving daily intraperitoneal
injections of 0.3 mg/kg of C21,9 or vehicle (Aqua ad iniectabilia). At 21 days,
the animals were trained in a standard hidden platform (place) task in the
Morris water maze, with a probe trial on the ﬁnal day. Exclusion criteria for
the water maze stipulated that any mice that did not learn the protocol
were excluded from the analysis (one animal each from groups 1 and 3).
Additionally, a technical malfunction on one of the probe trial days
resulted in the exclusion of the animals scheduled for testing that day
(seven mice from group 1 and four from group 3). Anatomic MRI
experiments were also performed at the ﬁnal timepoint on a subset of
mice from each group: Sham, Vehicle (n=14), Sham, C21 (n=3), Microcoil,
Vehicle (n= 20), and Microcoil, C21 (n= 11). Exclusion criteria for the
imaging results stipulated that any mice considered outliers (more than
1.5X the interquartile range) would be excluded from the analysis (one
animal from group 1). At the conclusion of the experiments, tissue was
harvested for ﬂow-cytometry analysis.
Chronic Hypoperfusion Via Bilateral Common Carotid Artery
Stenosis
Anesthesia was achieved using isoﬂurane in a 70:30 nitrous oxide:oxygen
mixture and core body temperature was maintained at 37.0 ± 0.2°C using
an automated heat blanket with temperature feedback. Animals were
placed in a supine position, a midline incision was made in the neck, and
the sternomastoid muscles were carefully retracted on both sides to
expose the carotid arteries. Chronic hypoperfusion was induced by
isolating the carotid arteries and wrapping microcoils (180 μm inner
diameter, Sawane Spring Company, Hamamatsu, Japan) around them. The
corresponding sham procedure was performed up to the point of
microcoil wrapping. All muscles and glands were guided back into place,
the incision sutured, and local anesthetic applied to the wound before
recovery.
Behavioral Testing
Sensorimotor function was assessed with the pole test, as previously
described.11 Brieﬂy, preoperative training was performed for 3 days with
four trials per day. Animals were tested before and at 7 and 14 days after
surgery. For each trial, mice were placed facing upward on the top of a 60-
cm pole and the time required for the animals to both turn to face
downward and descend to the home cage were recorded. Data from the
four daily trials were pooled. A standard place task in the Morris water
maze was used to assess spatial learning and reference memory. A circular
maze (120 cm diameter) was ﬁlled with opaque water to cover a sub-
merged escape platform (ﬁxed location). Three daily trials were performed
for each animal over 7 consecutive days. A trial consisted of lowering the
animal into the pool from different starting points and allowing them
90 seconds to ﬁnd the platform, or be collected. Trials were spaced 10
minutes apart and the animals were allowed to rest under a heat lamp in
between trials. Escape latency (seconds), total distance travelled (cm), and
swim speed (cm/s) were measured by a computerized tracking system
(VideoMot, TSE Systems, Bad Homburg, Germany). Data from the three
daily trials were pooled. At 8 days, a probe trial was performed in which the
platform was removed and the mice were allowed to swim for 90 seconds.
The total time spent in the former target quadrant (s) was assessed.
Magnetic Resonance Imaging Measurements
All MRI experiments were conducted on a 7T system (Bruker BioSpin,
Ettlingen, Germany). Anesthesia was again achieved using isoﬂurane (as
above) in spontaneously breathing mice, and body temperature and
respiration rate were monitored with MRI compatible equipment (Small
Animal Instruments, Inc., Stony Brook, NY, USA).
During the ﬁrst experiment, radio frequency transmission was achieved
with a 72-mm diameter quadrature resonator actively decoupled to a
mouse quadrature surface coil (Bruker BioSpin, Ettlingen, Germany). A
RARE (rapid acquisition relaxation enhancement) T2 sequence (repetition
time (TR)/echo time (TE): 5,000/10ms, 8 echoes, RARE factor: 2, resolution:
156 μm2, 16 minutes) was used to measure T2. The RARE sequence was
always acquired ﬁrst to allow the animal’s body temperature and respira-
tion rate to stabilize after induction of anesthesia. Subsequently, no adjust-
ments were made to the anesthetic levels during the CBF measurement,
as isoﬂurane is known to inﬂuence CBF. A single slice (1 mm) FAIR
(ﬂow-sensitive alternating inversion recovery) echo planar imaging (EPI)
sequence (TR/TE: 10,000/10ms, 10 inversion time (TIs) (30 to 2,500ms),
resolution: 195 μm2, 13 minutes) was used to measure CBF together with a
2mm 180° hyperbolic secant (sech80) inversion pulse (15ms). Degenera-
tion of the white matter was examined using an EPI DTI sequence (TR/TE:
4,000/29ms, 4 segments, 6 b values (0 to 2,000 s/mm2) with 5 b0 images,
30 gradient directions, gradient duration (δ) 7 ms, gradient separation (Δ)
15ms, resolution: 156 μm2 isotropic, 40 minutes).
During the second experiment, a 20-mm diameter quadrature volume
coil was used for radio frequency transmission and reception (RAPID
Biomedical, Rimpar, Germany); a volume coil is necessary for homogenous
signal during angiography measurements. The imaging protocol consisted
of a T2-weighted multislice multiecho sequence (TR/TE: 3,000/10.5 ms, 16
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Figure 1. Timelines of the experimental design. (A) First experiment:
T2-weighted imaging and cerebral blood ﬂow (CBF) were measured
before and at 4 and 24 hours, and 11, 17, and 25 days after microcoil
implantation. Diffusion tensor imaging (DTI) was performed at the
ﬁnal three timepoints. (B) Second experiment: Mice were tested for
sensorimotor function in the pole test and 1 week later underwent
microcoil implantation or sham surgery. At this time, they began
receiving daily intraperitoneal injections of Compound 21 (C21)
(0.3 mg/kg) or vehicle. They were tested in the pole test and a place
task in the Morris water maze was used to assess spatial learning
and reference memory. Finally, mice underwent anatomic magnetic
resonance imaging (MRI).
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echoes, resolution: 98 μm2, 9 minutes), and a 3D time of light angiography
sequence (TR/TE: 15/2.5 ms, α: 20˚, resolution: 98 μm3, 6 minutes).
Image Analysis
During the ﬁrst experiment, T2 and the different quantitative DTI
parameter maps were calculated using the Paravision software (Bruker
BioSpin, Ettlingen, Germany) and exported to ImageJ freeware (National
Institutes of Health). Several volumes of interest (VOIs) were chosen: the
entire cortex, striatum, corpus callosum, and internal capsule. Each of these
structures was manually delineated on a slice-by-slice basis on the T2-
weighted images; this created several individual regions of interest (ROIs)
for each structure. Subsequently, the ROIs were transferred to the FA maps
and distortions in the EPI images were accounted for by manually
adjusting the individual ROIs wherever necessary. Finally, integrated
density was used to extract the different quantitative parameters across
each VOI, thus providing one quantitative parameter value per structure.
A custom-written ImageJ Plugin was used to ﬁt T1 in the selective and
nonselective FAIR experiments, and subsequently calculate CBF. In the case
of the single slice CBF map, resolution only permitted identiﬁcation of two
ROIs: the striatum and the cortex.
During the second experiment, quantitative T2 maps were calculated
again using the Paravision software and data were rescaled by a factor of
10 and exported into FSL software (Analysis Group, FMRIB, Oxford, UK). For
the T2 images, the BET (brain extraction tool) was used to segment the
brain, and the process was completed manually. The FLIRT (FMRIB's linear
image registration tool) was used to co-register the segmented images to a
mouse brain template (average of 10 C57/BL6 mouse brains). Subse-
quently, the FAST (FMRIB’s automated segmentation tool) was used to
segment the ventricles. All resulting images were exported into ImageJ. A
binary mask was created for VOIs that corresponded to the striatum and
the corpus callosum. The mask was used to extract T2 across both VOIs in
each animal. Overall ventricle size and brain volumes were measured, and
the determinant from the coregistration process was used to extrapolate
the original volume. Angiography images were also exported to FSL and
the FLIRT was used to coregister them to the ﬁrst acquired data set.
Subsequently, the images were exported back into ImageJ and the same
volume was selected to build a maximum intensity projection of the Circle
of Willis using a custom-written Plugin. A threshold that corresponded to
roughly half of the signal in all the images (14,000) was chosen to exclude
most of the brain tissue and convert the maximum intensity projection to a
binary image. The images were visually inspected and voxels that did not
correspond to the vasculature were manually reset to 0. The overall size of
the Circle of Willis and basilar artery was calculated from the binary image
(by counting voxels with a value of 1), and the volumes were corrected
using the determinant.
Preparation of Mononuclear Cells from Brain and Blood for
Flow-Cytometry Analysis
Mice were euthanized at the conclusion of the experiments with intra-
peritoneal thiopental (25 mg) and blood samples were extracted from
the heart before perfusion with physiologic saline. Blood was incubated
with saline lysis buffer for 3 minutes at room temperature to eliminate
erythrocytes. Brains were removed and digested with collagenase
(Worthington Biochemical, Lakewood, NJ, USA) followed by mechanical
disaggregation. Mononuclear cells were isolated on a Percoll gradient (GE
Healthcare, Freiburg, Germany) by centrifugation for 20minutes at 450 g at
room temperature. Cells between 40% and 100% Percoll phases were
collected, washed with phosphate-buffered saline, and centrifuged.
After blocking of Fc receptors (2.4G2), antibodies against CD3 (145-
2C11), CD4 (GK1.5), CD8a (53-6.7), CD19 (1D3), CD11b (M1/70), and Ter119
(TER-119) were applied. All antibodies were purchased from eBiosciences
(San Diego, CA, USA), Miltenyi Biotec (Bergisch Gladbach, Germany), or
produced in-house (DRFZ, Berlin). A total of 2 × 106 cells were stained in
100 μL for 30minutes on ice in the dark. Data were acquired on LSRII (BD
Biosciences, Heidelberg, Germany) and analyzed by the FlowJo software
(Tree Star Inc., Ashland, OR, USA).
Statistical Analysis
Results were displayed as group means± standard deviation of the mean,
or, as quartiles in the box and whisker plots with the median, ﬁrst, and
third quartiles, as well as ranges, indicated. Statistical analysis was
performed using the SPSS Software (IBM, Ehningen, Germany) and a
P value of less than 0.05 was chosen as the signiﬁcance level for all
analyses. The Kolmogorov–Smirnov test was used to establish normal
distribution of the data and Levine’s test was used to establish normality of
variance. Cerebral blood ﬂow and DTI data were compared using two-way
repeated measures analysis of variance (ANOVA) with time and region as
the two within-subject factors. Water maze data were compared using a
mixed design two-way repeated measures ANOVA with surgery (sham
versus microcoil) and drug treatment (vehicle versus C21) as the between-
subject factors, and time as the within-subject factor. Performance in the
probe trial and angiography data were compared using a two-way ANOVA
with surgery and drug treatment as the two independent variables.
RESULTS
Quantitative Cerebral Blood Flow Imaging Reveals Distinctive
Patterns of Perfusion Changes after Microcoil Implantation
In the ﬁrst experiment, we monitored changes in T2 relaxivity and
CBF starting 4 hours after microcoil implantation in a separate
group of mice that did not undergo behavioral testing. Large
increases in T2 are associated with vasogenic edema and patho-
logy, but T2 was relatively stable over time in all three measured
VOIs: corpus callosum, internal capsule, and striatum (Figure 2A).
Due to the lower resolution of the CBF maps, we were only able to
isolate two ROIs: the cortex and the striatum. Nevertheless, CBF
decreased immediately after microcoil implantation (by more than
half) in both ROIs and subsequently increased to near presurgical
levels after approximately 3 weeks (main effect of time F(5,35)
2.753, P= 0.034, region F(1,7) 11.886, P= 0.011, and interaction F
(5,35) 2.737, P= 0.034); Figure 2B). Interestingly, three individual
patterns of CBF change were identiﬁed (Figure 2C). The ﬁrst was a
dramatic decrease immediately after microcoil implantation that
either recovered (top panel), or remained low (middle panel). The
remaining third of the mice exhibited only a small initial decrease
in CBF followed by little ﬂuctuation for the duration of the experi-
ments (bottom panel). Interestingly, one animal showed a delayed
decrease in CBF starting around 11 days. Though this animal did
not meet the predetermined exclusion criteria, the possibility
exists that this response could be an outlier.
Diffusion Tensor Imaging Reveals White-Matter Degeneration after
3 Weeks of Hypoperfusion
Diffusion tensor imaging is sensitive to water motion, which is
faster parallel (rather than perpendicular) to structures like axons.
Directional-dependent water diffusion is called anisotropy, thus,
white matter is generally identiﬁed by strong fractional anisotropy
(FA). Decreases in FA mean there is a directional-dependent
decrease in water diffusion, and the most common explanation
for this is white-matter damage. While FA has been shown to be
a useful parameter, measuring the entire diffusion tensor can
provide more detailed characterization of tissue microstructure
and pathology.12 Therefore, we measured changes in several
quantitative DTI parameters in the hypoperfused mouse brain:
FA, and mean, axial, and radial diffusivity (MD, AD, and RD,
respectively). There were no signiﬁcant changes in FA over time in
any of the three VOIs (internal capsule, corpus callosum, or
striatum) out to 25 days after microcoil implantation, though there
was a signiﬁcant main effect of region (F(2,12) 695.55, P= 0.001) as
FA values were higher in the white-matter structures when
compared with the striatum (data not shown). We observed
signiﬁcant main effects of region and time, but no interactions, for
all other DTI parameters: MD, AD, and RD. In general, structural
differences in all three parameters were apparent throughout the
measurement period, but parameters values increased in all three
VOIs, though to different degrees, between the third and fourth
postsurgical week (Figure 3). The increase in MD (the overall mean
diffusion, independent of direction) was the most dramatic
(Figure 3B; main effect of time (F(2,12) 11.067, P= 0.002) and
region (F(2,12) 81.858, P= 0.0001)), implying an overall reduction
in tissue integrity in all three VOIs. Overall increases in RD
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(diffusion perpendicular to the main direction) were less profound
(Figure 3C; main effect of time (F(2,12) 12.169, P= 0.001) and
region (F(1.1,6.6) 238.9, P= 0.0001)). However, they occurred to the
highest degree in the corpus callosum and internal capsule, which
is not surprising because both are white-matter structures and RD
increases are correlated with demyelination. Decreases in AD
(diffusion parallel to the main direction) have been correlated with
axonal degeneration. Interestingly, we observed increases in AD
corpus callosum internal capsule striatum
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Figure 2. Microcoil implantation resulted in decreased cerebral blood ﬂow (CBF) that partially recovered with time. (A) T2 and (B) CBF over
time (means± s.d.) in the hypoperfused mouse brain (n= 8). While T2 remained relatively stable, CBF decreased immediately after microcoil
implantation and subsequently increased over 3 weeks. (C) CBF and T2 maps of three individual animals indicate different patterns of CBF
change. Note: the scale bars correspond to CBF and T2 values.
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(Figure 3D; main effect of time (F(2,12) 6.592, P= 0.012) and region
(F(2,12) 345.23, P= 0.0001)) in all three structures and these effects
were most profound in the striatum.
Compound 21 Treatment Has Opposing Effects on Spatial
Reference Memory in Sham and Microcoil Mice
We aimed to examine sensorimotor and cognitive function in
hypoperfused mice with daily intraperitoneal administration of
either C21 or vehicle, starting at the time of surgery. No
sensorimotor impairments were observed in the pole test after
microcoil implantation, irrespective of treatment or surgery. All
mice were equally able to turn around on the pole (Figure 4A) and
descend into the home cage (Figure 4B). None of the groups
exhibited impairments in spatial learning in a water maze place
task (Figures 5A and 5B). All groups acquired the paradigm over
7 days and thus exhibited decreased escape latencies (main effect
of time F(3.809,209.481) 88.935, P= 0.0001) and travelled less
distance to ﬁnd the submerged platform (main effect of time F
(3.941,216.771) 103.498, P= 0.0001). There were no differences in
swim speed among the different groups (data not shown),
indicating again comparable sensorimotor abilities. When the
platform was removed during the probe trial on the ﬁnal test day,
there were no signiﬁcant main effects (for surgery or treatment).
However, there was a signiﬁcant interaction between surgery and
treatment (F(1,55) 5.336, P= 0.025; two-way ANOVA). Less time in
the target quadrant is used as an indicator of impaired spatial
reference memory. Interestingly, C21 had a positive effect on
microcoil mice (increased the amount of time spent in the target
quadrant), but had a negative effect on sham mice (decreased the
amount of time spent in the target quadrant) (Figures 5C and 5D).
Hypoperfusion Induced Arterial Remodelling of the Anterior
Region of the Circle of Willis
Bilateral common carotid artery occlusion in rats results in vascular
remodelling in the major cerebral arteries in response to sheer
stress,13 particularly the basilar artery.14 We used magnetic
resonance angiography to monitor changes in the arterial network
of hypoperfused mice treated with C21 or vehicle. Microcoil mice
exhibited increases in arterial tortuosity and diameter that were
most prominent in the anterior portion of the Circle of Willis,
rather than the basilar artery (Figure 6A). There was a signiﬁcant
main effect of surgery (F(1,44) 12.005, P= 0.001) in the overall size
of the Circle of Willis vasculature. The largest overall arterial
networks were observed in the microcoil vehicle-treated mice
when compared with the sham vehicle-treated mice (Figure 6B).
The effects of hypoperfusion on the basilar artery were less
profound, which is not surprising given the lack of collateralization
in mice; there was no signiﬁcant main effect of surgery. However,
the main effect of treatment just reached signiﬁcance (F(1,44)
4.110, P= 0.047). Post hoc comparisons revealed a treatment
difference only in the microcoil animals. Those treated with C21
exhibiting slightly larger basilar arteries than those treated with
vehicle (Figure 6C). We also calculated ventricle-to-brain ratio from
the T2-weighted images, which is generally used as an overall
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indicator of brain atrophy. Ventricle-to-brain ratio was reasonably
comparable among the groups despite high variability (data not
shown), suggesting no gross brain atrophy in any of the mice.
Compound 21 Treatment Promoted Lymphocyte Inﬁltration into
the Brain
We used ﬂow cytometry to estimate the proportion of lympho-
cytes, and their subtypes, in the brain and blood from animals in
each group at the conclusion of the experiments. Interestingly,
large increases in T and B cells and macrophages were observed in
the brains of all C21-treated animals (microcoil and sham) com-
pared with the corresponding vehicle-treated groups (Table 1).
This suggests that the microcoil model itself does not produce a
systemic inﬂammatory response, but that treatment with C21 is
capable of recruiting leukocytes to the brain. The same was true
for CD4+ T cells and B cells in the blood samples (data not shown).
DISCUSSION
This study identiﬁed different patterns of CBF change in a mouse
chronic hypoperfusion model, and increases in DTI indices that
suggest early white-matter degeneration in the brain. We also
showed that the AT2R agonist C21 differentially inﬂuenced spatial
reference memory in hypoperfused and sham mice. While we
cannot conﬁrm the exact mechanism behind this effect, it could,
in part, be mediated by increased brain lymphocyte inﬁltration,
which was observed after C21 treatment. Overall, our results
provide important outcome measures for future work with this
model, and suggest a role of the AT2R in VCI.
Vascular risk factors represent the ﬁrst step in the pathogenesis
of VCI. While we are the ﬁrst to use MRI to quantitatively report on
CBF changes in a mouse model of VCI, several groups have already
applied this technique in different strains of Alzheimer’s disease
mice, which highlights the importance of CBF imaging to study
vascular dysfunction in both Alzheimer’s disease and VCI.15,16
Cerebral blood ﬂow has been semiquantiﬁed in the cortex of
hypoperfused mice using Laser Doppler Flowmetry, and an acute
30% decrease was noted that also increased to near presurgical
levels within a month.3 Our quantitative measurements agree with
this, only we observed a greater initial decrease (approximately
50%) that was also present in subcortical structures. Both studies
reported a high degree of variability in the CBF measurements.
However, this is not necessarily surprising for Laser Doppler, or for
FAIR EPI-based measurements that are extremely difﬁcult to
perform in the small mouse brain. With this technique in the
mouse, there is a very high level of noise, the standard deviation
of the noise is approximately 25%. This makes it difﬁcult to
accurately measure the small difference in T1 signal between the
selective and nonselective experiments. Despite making effort to
maintain a constant level of anesthetic, there may have also been
slight differences in physiologic parameters that contributed to
interanimal variability. One of the most important ﬁndings of the
present work is that we were able to identify different patterns of
CBF change among hypoperfused animals, which highlights the
utility of CBF imaging as an outcome measure in this model. It is
possible that some of the animals that exhibited CBF recovery may
not have had sufﬁcient maintenance of the induced stenosis.
Indeed, we can not exclude this possibility as the high amount of
ﬁbrous deposits on the coils and arteries prevented extraction of
the carotids to examine them histologically. We also performed
DTI in the same group of hypoperfused mice to obtain an
additional outcome measure. White-matter hyperintensities in T2-
weighted or FLAIR images are a useful hallmark of certain VCI
subtypes. Furthermore, DTI is a predictor of cognitive decline in
patients with leukoaraiosis,17 and is a promising technique to
identify presymptomatic microstructural changes in white mat-
ter.18 We measured signiﬁcant increases in MD, RD, and AD in
several brain structures. It is well accepted that MD and RD
increases represent a loss of tissue integrity and demyelination,
respectively;19 the present study conﬁrms this. While MD increases
were present in all measured structures, implying an overall loss of
tissue integrity, the greatest increases in RD occurred in the white-
matter structures (internal capsule and corpus callosum) when
compared with the striatum (a mixture of white and gray matter).
Other studies have reported that decreases in AD were correlated
with axonal injury.15,20 We observed instead an increase in AD,
particularly in the corpus callosum and striatum. This may be due
to the fact that AD can be inﬂuenced by axonal swelling and/or
transport disruption that mask axonal injury.20 However, a DTI
study of patients with small vessel disease noted increases in AD,
which were interpreted as arteriopathy unique to lacunar
infarction and leukoaraiosis.21 The increase in AD may also imply
that there is little axonal injury in this model. This is in agreement
with the only other DTI study in hypoperfused mice that observed
evidence of demyelination (instead of axonal injury) that was
correlated with a subtle decrease in FA in the corpus callosum and
the internal capsule.22 We did not observe a decrease in FA. This
discrepancy may be the result of differences in sequence
parameters; the other group did not use isotropic voxels, which
makes it difﬁcult to accurately measure diffusivity indices.
However, the lack of decrease in FA may not be entirely surprising
as FA is a gross measure of anisotropy. Diffusivity indices,
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Figure 4. Hypoperfusion, irrespective of Compound 21 (C21)
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into the home cage in all four groups.
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particularly MD, have been shown to be better predictors of small
vessel disease.21 We attempted to correlate the degree of CBF
deﬁcit at 4 hours with the AD diffusivity values at 25 days, as we
hoped that the initial CBF decrease would be a useful predictor of
ﬁnal outcome. However, no correlation was observed. This may be
due to the relatively small sample size, or the fact that there was a
very small dynamic range of observed DTI values. This remains a
limitation of the present study and future work is required to
improve the predictive ability of the model.
While spatial working memory impairments have been reported
in microcoil mice in the radial arm maze, spatial learning in the
water maze has remained intact.4,5 Our results are in agreement,
except that we found spatial reference memory impairments in
the water maze during the probe trial. It should be noted that this
was not consistently observed, which again suggests this model is
more variable than previously reported. The most interesting
ﬁnding of the present study was the signiﬁcant interaction
between surgery and treatment during the probe trial. Compound
21 both improved and impaired spatial reference memory in
microcoil and sham animals, respectively, suggesting pleotropic
effects on cognitive function. Another study reported C21 enhanced
cognitive function in normal mice because spatial learning, but
not reference memory, was improved in the water maze.9 In the
same study, spatial learning improvements were detected on day
5 of water maze training in C21-treated Alzheimer’s mice. The
authors speculated these effects were mediated by enhancement
of hippocampal excitatory postsynaptic potentials. Similar ﬁndings
were reported when C21 treatment was combined with meman-
tine (Alzheimer’s treatment) in diabetic mice.23 While we did not
examine neurotrophic processes in the hippocampus, we did
observe a subtle increase in the size of the basilar artery in C21-
treated microcoil mice. The blood supply to the hippocampus is
provided by the posterior cerebral artery, which branches off the
superior cerebellar from the basilar artery. Therefore, it is possible
that the larger basilar arteries observed in hypoperfused C21-
treated animals may have resulted in a slightly improved blood
supply to the vulnerable hippocampus, thus assisting with the
preservation of spatial reference memory in this group when
compared with the vehicle-treated animals. While C21 does not
inﬂuence blood pressure, it has been shown to induce vasodila-
tion in rat and mouse arteries via an AT2R receptor-independent
mechanism.24 We also observed an increase in lymphocyte
inﬁltration into the brains of C21-treated mice. It is possible that
these inﬁltrating cells may have partially inﬂuenced the differential
effects we observed in spatial reference memory. Indeed, a recent
study showed that cardiovascular injury, in addition to inducing
potentially cytotoxic CD8+ T cells, also promoted the release of
subpopulations of T cells that expressed AT2R.25 These AT2R+
T cells were capable of producing IL-10 and were protective in
another cohort of animals with myocardial infarction. Interestingly,
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Figure 5. The effects of hypoperfusion and Compound 21 (C21) on spatial learning and reference memory. (A) Escape latency and (B) total
distance travelled by each group during the place task in the Morris water maze (means± s.d.). (C) Representative swim paths from an animal
in each group and (D) total time spent in the target quadrant (#4) during the probe trial. Note: The * corresponds to post-hoc Bonferonni
corrected multiple comparisons.
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another study reported that low doses of C21 do not inﬂuence
leukocyte migration to the stroke brain, though administration did
result in neuroprotection, likely due to the upregulation of
inducible nitric oxide synthase that would have reduced produc-
tion of the damaging free radical nitric oxide.26
In conclusion, we have successfully applied neuroimaging to
identify several new outcome measures in a mouse model of
chronic hypoperfusion, these outcome measures are applicable in
humans, and may serve to facilitate translation of knowledge
between bench and bedside. We have also shown beneﬁcial
effects of C21 on spatial reference memory only in hypoperfused
mice, though the exact mechanism still requires investigation, this
suggests that the RAS has a role in VCI.
DISCLOSURE/CONFLICT OF INTEREST
The authors declare no conﬂict of interest.
REFERENCES
1 Jiwa NS, Garrard P, Hainsworth AH. Experimental models of vascular dementia
and vascular cognitive impairment: a systematic review. J Neurochem 2010; 115:
814–828.
Microcoil
Sham
Vehicle C21
0
50
100
150
Sham Microcoils
B
a
s
il
a
r 
a
rt
e
ry
 s
iz
e
 (
µ
m
2
)
Groups
300
500
700
900
Sham Microcoils
S
iz
e
 o
f 
v
a
s
c
u
la
tu
re
 (
µ
m
2
)
Groups
*
*
Figure 6. The effects of hypoperfusion and Compound 21 (C21) on vascular remodelling. (A) Representative maximum intensity projections of
the Circle of Willis in sham and microcoil animals. (B) Overall size of the Circle of Willis vasculature and (C) basilar artery (Sham, Vehicle (n= 14);
Sham, C21 (n= 3); Microcoil, Vehicle (n= 20); Microcoil, C21 (n= 11)). Note: The * corresponds to post hoc Bonferonni corrected multiple
comparisons.
Table 1. Increased lymphocyte inﬁltration into the brains of C21-treated animals
T cells (CD3+) B cells (CD3-) Macrophages (CD3-)
CD8+ CD4+ CD19+ Mac-1+
Sham, Vehicle 13.7± 1.6 1.5± 0.7 21.6± 6.8 5.4± 1.6
Sham, C21 29.7± 2.8 48.0± 3.9 40.4± 4.8 20.5± 2.1
Microcoil, Vehicle 16.8± 4.1 7.5± 11.0 11.8± 5.3 7.2± 2.0
Microcoil, C21 28.7± 2.2 50.7± 2.4 42.1± 10.3 20.1± 4.9
C21, Compound 21. Expressed as a percentage of the lymphocyte parental cell population (n= 4 per group).
Effects of angiotensin type 2 receptor in a mouse model of VCI
M Füchtemeier et al
483
© 2015 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2015), 476 – 484
2 Sarti C, Pantoni L, Bartolini L, Inzitari D. Persistent impairment of gait perfor-
mances and working memory after bilateral common carotid artery occlusion in
the adult Wistar rat. Behav Brain Res 2002; 136: 13–20.
3 Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial acti-
vation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004;
35: 2598–2603.
4 Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, Ohtani R et al. Selective
impairment of working memory in a mouse model of chronic cerebral hypo-
perfusion. Stroke 2007; 38: 2826–2832.
5 Coltman R, Spain A, Tsenkina Y, Fowler JH, Smith J, Scullion G et al. Selective white
matter pathology induces a speciﬁc impairment in spatial working memory.
Neurobiol Aging 2011; 32: 2324, e7–e12.
6 Nishio K, Ihara M, Yamasaki N, Kalaria RN, Maki T, Fujita Y et al. A mouse model
characterizing features of vascular dementia with hippocampal atrophy. Stroke
2010; 41: 1278–1284.
7 Miki K, Ishibashi S, Sun L, Xu H, Ohashi W, Kuroiwa T et al. Intensity of chronic
cerebral hypoperfusion determines white/gray matter injury and cognitive/motor
dysfunction in mice. J Neurosci Res 2009; 87: 1270–1281.
8 Guimond M-O, Gallo-Payet N. How does angiotensin AT(2) receptor activation
help neuronal differentiation and improve neuronal pathological situations? Front
Endocrinol (Lausanne) 2012; 3: 164.
9 Jing F, Mogi M, Sakata A, Iwanami J, Tsukuda K, Ohshima K et al. Direct stimulation
of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow
Metab 2012; 32: 248–255.
10 Sumners C, Horiuchi M, Widdop RE, McCarthy C, Unger T, Steckelings UM et al..
Protective arms of the renin-angiotensin-system in neurological disease. Clin Exp
Pharmacol Physiol 2013; 40: 580–588.
11 Balkaya M, Kröber J, Gertz K, Peruzzaro S, Endres M. Characterization of long-term
functional outcome in a murine model of mild brain ischemia. J Neurosci Methods
2013; 213: 179–187.
12 Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain.
Neurotherapeutics 2007; 4: 316–329.
13 Buschmann IR, Busch HJ, Mies G, Hossmann KA. Therapeutic induction of arter-
iogenesis in hypoperfused rat brain via granulocyte-macrophage colony-
stimulating factor. Circulation 2003; 108: 610–615.
14 Soria G, Tudela R, Márquez-Martín A, Camón L, Batalle D, Muñoz-Moreno E et al.
The ins and outs of the BCCAo model for chronic hypoperfusion: a multimodal
and longitudinal MRI approach. PLoS ONE 2013; 8: e74631.
15 Zerbi V, Jansen D, Wiesmann M, Fang X, Broersen LM, Veltien A et al. Multinutrient
diets improve cerebral perfusion and neuroprotection in a murine model of
Alzheimer’s disease. Neurobiol Aging 2014; 35: 600–613.
16 Lin A-L, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ et al. Chronic
rapamycin restores brain vascular integrity and function through NO synthase
activation and improves memory in symptomatic mice modeling Alzheimer’s
disease. J Cereb Blood Flow Metab 2013; 33: 1412–1421.
17 Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F et al. Diffusion
changes predict cognitive and functional outcome: the LADIS study. Ann Neurol
2013; 73: 576–583.
18 López-Gil X, Amat-Roldan I, Tudela R, Castañé A, Prats-Galino A, Planas AM et al.
DWI and complex brain network analysis predicts vascular cognitive impairment
in spontaneous hypertensive rats undergoing executive function tests. Front
Aging Neurosci 2014; 6: 167.
19 Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH et al. Demyelination
increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;
26: 132–140.
20 Xie M, Tobin JE, Budde MD, Chen C-I, Trinkaus K, Cross AH et al. Rostrocaudal
analysis of corpus callosum demyelination and axon damage across disease
stages reﬁnes diffusion tensor imaging correlations with pathological features.
J Neuropathol Exp Neurol 2010; 69: 704–716.
21 Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR et al.
Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal
MRI results from the St George’s cognition and neuroimaging in stroke
(SCANS) study. PLoS ONE 2013; 8: e61014.
22 Holland PR, Bastin ME, Jansen MA, Merriﬁeld GD, Coltman RB, Scott F et al. MRI is a
sensitive marker of subtle white matter pathology in hypoperfused mice. Neuro-
biol Aging 2011; 32: 2325 e1–6.
23 Iwanami J, Mogi M, Tsukuda K, Jing F, Ohshima K, Wang X-L et al. Possible
synergistic effect of direct angiotensin II type 2 receptor stimulation by com-
pound 21 with memantine on prevention of cognitive decline in type 2
diabetic mice. Eur J Pharmacol 2014; 724: 9–15.
24 Verdonk K, Durik M, Abd-Alla N, Batenburg WW, van den Bogaerdt AJ,
van Veghel R et al. Compound 21 induces vasorelaxation via an endothelium- and
angiotensin II type 2 receptor-independent mechanism. Hypertension 2012; 60:
722–729.
25 Curato C, Slavic S, Dong J, Skorska A, Altarche-Xifró W, Miteva K et al. Identiﬁcation
of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to
ischemic heart injury. J Immunol 2010; 185: 6286–6293.
26 Joseph JP, Mecca AP, Regenhardt RW, Bennion DM, Rodríguez V, Desland F et al.
The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotec-
tion in endothelin-1 induced ischemic stroke. Neuropharmacology 2014; 81C:
134–141.
This work is licensed under a Creative Commons Attribution 3.0
Unported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by/3.0/
Effects of angiotensin type 2 receptor in a mouse model of VCI
M Füchtemeier et al
484
Journal of Cerebral Blood Flow & Metabolism (2015), 476 – 484 © 2015 ISCBFM
